Page 3 - Rog Eb News Today

By Colin Kellaher Shares of Tempest Therapeutics rose more than sevenfold in premarket trading Wednesday after the clinical-stage oncology company reported...

By Colin Kellaher AbbVie on Friday said a Phase 3 study evaluating the safety and efficacy of its venetoclax cancer drug in combination with dexamethasone...

By Giulia Petroni Roche said the U.K.'s medicines regulator has approved its Tecentriq intravenous cancer therapy. The Swiss pharmaceutical company said...

By Adria Calatayud Shares in Roche Holding rose Wednesday after the company released interim results from a late-stage clinical trial of a combination of two...

By Adria Calatayud Roche Holding on Thursday backed its guidance for 2023 after lower sales of products related to Covid-19 in the first half weighed on its...

By Adria Calatayud Roche Holding is scheduled to report results for the first half on Thursday. Here is what you need to know: SALES FORECAST: The Swiss...

By Sarah Sloat Swiss pharma company Roche said Friday it has received a positive opinion from the European Union that would extend use of its Evrysdi...

Health-care companies rallied after strong earnings for the largest health insurer by enrollees. Shares of UnitedHealth surged, rising by more than 7% after...

Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days

The Food and Drug Administration rejected its application for approval of a new, higher-dose version of eye disease treatment Eylea.